Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of ACZONE Gel in G6PD-Deficient Acne Patients
NCT00243542Phase 4Completed
- Sponsor
- Allergan
- Start
- Nov 2005
- Primary completion
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dapsone in acne vulgaris (2 arms), sponsored by Allergan. Primary endpoints: Change in laboratory parameters related to hemolysis at 12 weeks, Adverse Events and 1 more. Started Nov 2005; status: completed.
02
Drugs
dapsone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT00243542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00243542.